Who invested in AlloCure?
AlloCure's investors include SV Life Sciences, Novo Holdings A/S and Lundbeckfond Ventures.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$47Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by masshightech.comSEC filing: $17M sold, first sale Mar 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $1.5M sold, first sale Sept 2011
No investor was named in the report.
From a historical funding recordSEC filing: $5.6M sold, first sale Nov 2009
No investor was named in the report.
From a historical funding recordSEC filing: $400K sold, first sale Jun 2009
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid Kirstine GuyerMette Kirstine AggerScott Kirstine CanuteThomas B. Dyrberg
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
AlloCure's investors include SV Life Sciences, Novo Holdings A/S and Lundbeckfond Ventures.
AlloCure has raised $47M across 5 rounds since 2008.
AlloCure's most recent round was a Series B of $25M in Apr 2012.
Its most recent round, $25M in Apr 2012, is also its largest on record.
AlloCure's first round on record, in Jul 2008, was backed by SV Life Sciences and Novo Holdings A/S.
AlloCure's latest named round is a Series B, in Apr 2012.
AlloCure is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.